Saturday, August 30, 2014 9:28:53 PM
Published: Aug 29, 2014 4:44 p.m. ET
Click For marketwatch.com Link
STAMFORD, Conn., Aug 29, 2014 (BUSINESS WIRE) -- SYNCHRONY FINANCIAL (“Synchrony”) announced that the underwriters for its initial public offering of common stock have partially exercised their option to purchase additional shares and purchased an additional 3,493,756 shares.
The additional shares will be sold at the public offering price of $23.00, before underwriting discounts and commissions. The sale of the option shares is expected to close on September 3 and, after giving effect that sale, the total number of shares sold by Synchrony in the initial public offering will be 128,493,756 shares, the total net proceeds from the initial public offering received by Synchrony will be approximately $2.8 billion and General Electric Company will own approximately 84.6% of Synchrony’s common stock.
A registration statement relating to this offering was filed with, and declared effective by, the Securities and Exchange Commission on July 30, 2014. The offering was made solely by means of a prospectus. This press release shall not constitute an offer to sell or a solicitation of an offer to buy, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction. Copies of the final prospectuses may be obtained from:
Goldman, Sachs & Co., 200 West Street, New York, NY 10282, facsimile: 212-902-9316, Attention: Prospectus Department, or by calling 866-471-2526 or emailing prospectus-ny@ny.email.gs.com;
J.P. Morgan Securities LLC, c/o Broadridge Financial Solutions, 1155 Long Island Avenue, Edgewood, NY 11717, Attention: Prospectus Department, or by calling 866-803-9204;
Citigroup Global Markets Inc., c/o Broadridge Financial Solutions, 1155 Long Island Avenue, Edgewood, NY 11717, or by calling 800-831-9146; or
Morgan Stanley & Co. LLC, 180 Varick Street, 2nd Floor, New York, NY 10014, Attention: Prospectus Department.
TRUTH
I've never claimed to have all the answers but feel i'm beginning to corner the market in questions worthy of solutions.
Recent SYF News
- Synchrony Extends Partnership with Affordable Care Offering CareCredit to Patients • PR Newswire (US) • 05/02/2024 01:00:00 PM
- Synchrony and ServiceTitan Join Forces to Streamline Home Improvement Financing • PR Newswire (US) • 04/30/2024 01:00:00 PM
- Synchrony Reports First Quarter 2024 Results; Company also Announces Quarterly Stock Dividends and Approval of an Incremental $1.0 Billion Share Repurchase Program • PR Newswire (US) • 04/24/2024 10:13:00 AM
- Synchrony Expands Dental Payment Offerings with Adit Practice Management Software Partnership • PR Newswire (US) • 04/18/2024 01:00:00 PM
- Synchrony Partners with BRP to Provide Retail Financing Options in the United States • PR Newswire (US) • 04/08/2024 01:00:00 PM
- SYNCHRONY RECOGNIZED FOR ITS PEOPLE-CENTRIC CULTURE WITH NEW COMPANY RANKING • PR Newswire (US) • 04/04/2024 12:38:00 PM
- Synchrony to Announce First Quarter 2024 Financial Results on April 24, 2024 • PR Newswire (US) • 03/26/2024 12:00:00 PM
- Skipify and Synchrony Enter into Strategic Partnership to Simplify and Enhance Online Checkout • PR Newswire (US) • 03/13/2024 01:00:00 PM
- IPH ENTERS STRATEGIC PARTNERSHIP WITH SYNCHRONY AND COMPLETES ACQUISITION OF PETS BEST • PR Newswire (US) • 03/06/2024 04:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/06/2024 12:30:26 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/06/2024 12:30:09 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/06/2024 12:29:56 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/06/2024 12:29:35 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/06/2024 12:29:20 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/06/2024 12:29:07 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/06/2024 12:28:56 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/06/2024 12:28:41 AM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/05/2024 10:24:06 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/05/2024 09:40:35 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/05/2024 09:00:31 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/05/2024 08:45:25 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/05/2024 06:52:54 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/05/2024 05:41:24 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/05/2024 01:30:44 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/04/2024 04:42:46 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM